Clinical trial · Interventional
A Prospective Study to Evaluate the Performance of a Real-time System in the Estimation of Colorectal Polyp Size
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Colorectal polyp size is related to the risk of exhibiting advanced histological features. Moreover, polyps larger than 10 mm are associated with an elevated risk of metachronous advanced neoplasia and colorectal cancer (CRC). Consequently, accurate measurement of polyp size, especially at the 10 mm threshold is critical for risk stratification and surveillance intervals. Furthermore, polyp size is also important for the choice of the appropriate resection procedures. Underestimation may lead to delayed diagnosis, thereby increasing the risk of colorectal cancer, while overestimation may result in unnecessary surveillance endoscopies.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Artificial Intelligence (AI) | — | UNRESOLVED | — |
| Colonic Polyps | — | UNRESOLVED | — |
| CRC (Colorectal Cancer) | Colorectal Carcinoma | ALIAS | 0.85 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| EndoAIM | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- ENDOAIM used arm
- description
- ENDOAIM will be used during withdrawal phase of colonoscopy
- interventionNames
- Device: EndoAIM
Primary outcomes (1)
- measure
- The primary endpoint is the difference in percentage for each measurement in discriminating polyp size at the 10mm threshold
- timeFrame
- During the colonoscopy
- description
- The primary endpoint is the difference in percentage for each measurement in discriminating polyp size at the 10mm threshold
Secondary outcomes (4)
- measure
- The percentage of correctness of each measurement in discriminating polyp size at the 5 mm threshold
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: Subjects are eligible if: 1. They have received colonoscopy for screening, surveillance or symptom investigation; 2. Aged 18 years older or above; 3. Written informed consent obtained. Exclusion Criteria: Subjects are excluded if they have: 1. Contraindication to colonoscopy (e.g. intestinal obstruction or perforation) 2. Contraindication or conditions precluding polyp resection (e.g. active gastrointestinal bleeding, uninterrupted anticoagulation or dual antiplatelets) 3. Advanced comorbid conditions (defined as American Society of Anesthesiologists grade 4 or above)
References
Publications (0)
Data not yet available